Intraperitoneal and Appendiceal Malignancies
Intraperitoneal and Appendiceal Malignancies is a research topic within Surgery. Science Explorer counts 20k research works in it since 1950. 15.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management of peritoneal carcinomatosis from digestive tract cancers, particularly colorectal cancer and gastric cancer. It includes studies on cytoreductive surgery, intraperitoneal chemotherapy, hyperthermic intraperitoneal chemotherapy, and survival analysis in patients with peritoneal metastases. The cluster also covers topics such as pseudomyxoma peritonei, appendiceal neoplasms, and the treatment of peritoneal surface malignancy.
- Cytoreductive Surgery
- Intraperitoneal Chemotherapy
- Colorectal Cancer
- Peritoneal Metastases
- Pseudomyxoma Peritonei
- Hyperthermic Intraperitoneal Chemotherapy
- Gastric Cancer
- Appendiceal Neoplasms
- Survival Analysis
- Peritoneal Surface Malignancy
- Research works
- 20k fractional, since 1950
- In the world top 10%
- 3.1k per year above
- Top-10% rate
- 15.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +41% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Intraperitoneal and Appendiceal Malignancies research?
By volume, the United States and China publish the most (786 and 570 works in 2022–2025).
By volume, 2022–2025
- 1 United States 786 works
- 2 China 570 works
- 3 India 256 works
- 4 Japan 252 works
- 5 United Kingdom 191 works
- 6 Italy 158 works
- 7 Türkiye 139 works
- 8 Spain 138 works
- 9 France 129 works
- 10 Germany 121 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Intraperitoneal and Appendiceal Malignancies research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Intraperitoneal and Appendiceal Malignancies research, followed by All India Institute of Medical Sciences and Sağlık Bilimleri Üniversitesi.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 35 works
- 2 All India Institute of Medical SciencesIndia 19 works
- 3 Sağlık Bilimleri ÜniversitesiTürkiye 16 works
- 4 Sun Yat-sen UniversityChina 16 works
- 5 Memorial Sloan Kettering Cancer CenterUnited States 15 works
- 6 Agostino Gemelli University PolyclinicItaly 15 works
- 7 Cleveland ClinicUnited States 14 works
- 8 Istituti di Ricovero e Cura a Carattere ScientificoItaly 13 works
- 9 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 12 works
- 10 Peking UniversityChina 11 works
Where is Intraperitoneal and Appendiceal Malignancies research done?
The largest centres of Intraperitoneal and Appendiceal Malignancies research in 2022–2025 are Beijing (China), Tokyo (Japan), Guangzhou (China) and Seoul (South Korea).
Largest cities, 2022–2025
Where is the best place to study Intraperitoneal and Appendiceal Malignancies?
Among universities, judged by research, Università Cattolica del Sacro Cuore, Radboud University Nijmegen and All India Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Università Cattolica del Sacro CuoreItaly | 62.6 | 34.2% | 8.5× | 10 | +43.1% |
| 2 | Radboud University NijmegenNetherlands | 51.9 | 30.8% | 4.9× | 8 | +39.0% |
| 3 | All India Institute of Medical SciencesIndia | 49.1 | 4.4% | 7.9× | 19 | +187.1% |
| 4 | Sağlık Bilimleri ÜniversitesiTürkiye | 44.7 | 7.1% | 7.2× | 16 | — |
| 5 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 39.4 | 17.0% | 3.1× | 12 | +151.6% |
| 6 | Capital Medical UniversityChina | 32.0 | 17.4% | 3.9× | 9 | — |
| 7 | Sichuan UniversityChina | 31.0 | 29.3% | 1.2× | 8 | +29.4% |
| 8 | Sun Yat-sen UniversityChina | 30.7 | 11.9% | 2.5× | 16 | +37.3% |
| 9 | University of ChicagoUnited States | 29.9 | 11.6% | 3.0× | 10 | +110.4% |
| 10 | Peking UniversityChina | 23.7 | 12.4% | 1.8× | 11 | +4.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Intraperitoneal and Appendiceal Malignancies research growing?
Output in 2018–2022 was 41% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Intraperitoneal and Appendiceal Malignancies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.